Skip to main content
SpringerLink
Log in

Parvovirus B19-Infektion

  • Conference paper
20. Hämophilie-Symposion Hamburg 1989

Zusammenfassung

Das humane Parvovirus B19 wurde 1975 zufällig beim Screening von Blutkonserven auf das Oberflächenantigen des Hepatitis B-Virus in Plasmen gesunder Blutspender entdeckt [1]. Aufgrund seiner physikalisch-chemischen Eigenschaften ließ es sich der Familie der Parvoviridae zuordnen. Bis zum Anfang der 80er Jahre allerdings konnte dieses Virus mit keiner klinischen Symptomatik assoziert werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Cossart YE, Cant B, Field AM, Widdows D (1975) Parvoviras-like particles in human sera. Lancet ii :72–73

    Article  Google Scholar 

  2. Mori J, Beattie P, Melton DW, Cohen BJ, Clewley JP (1987) Structure and mapping of the DNA of human parvovirus B19. J gen Virol 68:2797–2806

    Article  PubMed  CAS  Google Scholar 

  3. Ozawa K, Kurtzman G, Young N (1986) Replication of the B19 parvovirus in human bone marrow cell cultures. Science 233:883–886

    Article  PubMed  CAS  Google Scholar 

  4. Yaegashi N, Shiraishi H, Takeshita T, Nakamura M, Yajima A, Sugamura K (1989) Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J Virol 63:2422–2426

    PubMed  CAS  Google Scholar 

  5. Takahashi T, Ozawa K, Mitani K, Miyazono K, Asano S, Takaku F (1989) B19 parvovirus replicates in erythroid leukemic cells in vitro. J Inf Dis 160:548–549

    Article  CAS  Google Scholar 

  6. Schwarz TF, Roggendorf M, Deinhardt F (1987) Häufigkeit der Parvovirus B19-Infektio-nen — Seroepidemiologische Untersuchungen. Dtsch Med Wochenschr 112:1526–1531

    Article  PubMed  CAS  Google Scholar 

  7. Cohen BJ, Buckley MM (1988) The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 25:151–153

    Article  PubMed  CAS  Google Scholar 

  8. Schwarz TF, Gürtler LG, Zoulek G, Deinhardt F, Roggendorf M (1989) Seroprevalence of human parvovirus B19 infection in Sao Tomé and Principe, Malawi and Mascarene Islands. Zbl Bakt 271:231–236

    CAS  Google Scholar 

  9. Schwarz TF, Roggendorf M, Deinhardt F (1987) Human parvovirus B19 infections in the UK 1984–86. Lancet i :738–739

    Google Scholar 

  10. Anderson MJ, Pattison JR (1984) The human Parvovirus: Brief review. Arch Virol 82:137–148

    Article  PubMed  CAS  Google Scholar 

  11. Werner GH (1958) Erythema infectiosum. Klin Wschr 36:49–55

    Article  PubMed  CAS  Google Scholar 

  12. Schwarz TF, Jäger G, Schlipköter UA, Wiersbitzky S, Tiller FW, Hottenträger B, Deinhardt F, Roggendorf M (1990) Parvovirus B19 Infektionen in Deutschland 1987–88. Öff Gesundh-Wes 52:53–57

    CAS  Google Scholar 

  13. Schwarz TF, Roggendorf M, Deinhardt F (1987) Parvovirus B19-Infektionen — Ausbrach in einer medizinisch-technischen Lehranstalt. Dtsch Med Woschenschr 112:1190

    CAS  Google Scholar 

  14. Center for Disease Control (1989) Risk associated with human parvovirus B19 infection. Morb Mort Weekly Rep 38:81–97

    Google Scholar 

  15. Serjeant GH, Mason R, Topley JM, Serjeant BE (1981) Outbreak of aplastic crisis in sickle cell anaemia associated with parvoviras-like agent. Lancet ii :595–597

    Article  Google Scholar 

  16. Kelleher JF, Luban NLC, Mortimer PP, Kamimura T (1983) Human serum parvovirus: A specific cause of aplastic crisis in children with hereditary spherocytosis. J Pediatrics 102:720–722

    Article  CAS  Google Scholar 

  17. Schwarz TF, Roggendorf M, Janka-Schaub G (1988) Aplastic crisis caused by parvovirus B19. Eur J Clin Microbiol Infect Dis 7:87–88

    Article  PubMed  CAS  Google Scholar 

  18. Wiersbitzky S, Schwarz TF, Schröder C, Bruns R, Jäger G, Ladstätter L (1989) Vaskuläre Purpura und andere Gefäß- und Kreislaufalterationen bei Kindern mit akuter Parvovirus B19-Infektion. Kinderärztl Prax 57:193–197

    PubMed  CAS  Google Scholar 

  19. Aussedat R, Fesser P, Pourel J (1987) Coxite aigue de l’adolescent, manifestation unique d’une infection par le parvovirus B19. La Presse Med 16:1978

    CAS  Google Scholar 

  20. Morinet F, Monsuez JJ, Roger R, Perol Y (1987) Parvovirus B19 associated with pseudoappendicitis. Lancet ii :1466

    Article  Google Scholar 

  21. Schwarz TF, Roggendorf M, Suschke H, Deinhardt F (1987) Human parvovirus B19 infection and juvenile chronic polyarthritis. Infection 15:264–265

    Article  PubMed  CAS  Google Scholar 

  22. Walsh KJ, Armstrong RD, Turner AM (1988) Brachial plexus neuropathy associated with human parvovirus infection. Br Med J 296:896

    Article  CAS  Google Scholar 

  23. Kurtzman GJ, Ozawa K, Cohen BJ, Hanson G, Oseas R, Young NS (1987) Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 317:287–294

    Article  PubMed  CAS  Google Scholar 

  24. Kurtzman GJ, Cohen B, Meyers P, Amunullah A, Young NS (1988) Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet ii :1159–1162

    Article  Google Scholar 

  25. Coulombel L, Morinet F, Mielot F, Tchernia G (1989) Parvovirus infection, leukaemia, and immunodeficiency. Lancet i :101–102

    Article  Google Scholar 

  26. Davidson JE, Gibson B, Gibson A, Evans TJ (1989) Parvovirus infection, leukaemia and immunodeficiency. Lancet i :102

    Google Scholar 

  27. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS (1989) Pure red-cell aplasia of 10 years’ duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 321:519–523

    Article  PubMed  CAS  Google Scholar 

  28. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd JM, Pattison JR, Tyrrell DAJ (1985) Experimental parvoviral infection in humans. J Inf Dis 152:257–265

    Article  CAS  Google Scholar 

  29. Schwarz TF, Roggendorf M, Deinhardt F (1988) Human parvovirus B19: ELISA and immunoblot assays. J Virol Methods 20:155–168

    Article  PubMed  CAS  Google Scholar 

  30. Cohen BJ, Mortimer PP, Pereira MS (1983) Diagnostic assays with monoclonal antibodies for the human serum parvoviras-like virus (SPLV) J Hyg Camb 91:113–130

    Article  PubMed  CAS  Google Scholar 

  31. Courouce AM, Beaulieu MJ, Boucharcteau F, Lenel ML, Le Maree N (1985) Viraemia with human parvovirus. Lancet i :1218

    Article  Google Scholar 

  32. Kajigaya S, Shimada T, Fujita S, Young NS (1989) A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sci USA 86:7601–7605

    Article  PubMed  CAS  Google Scholar 

  33. Salimans MMM, Holsappel S, van de Rijke FM, Jiwa NM, Raap AK, Weiland HT (1989) Rapid detection of human parvovirus B19 DNA by dot-hybridization and the polymerase chain reaction. J Virol Methods 23:19–28

    Article  PubMed  CAS  Google Scholar 

  34. Mortimer PP, Luban NLC, Kelleher JF (1983) Transmission of serum parvo virus-like virus by clotting-factor concentrates. Lancet ii:482–484

    Article  Google Scholar 

  35. Bartolomei Corsi O, Azzi A, Morfini M, Fauci R, Rossi Ferrini P (1988) Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 25:165–170

    Article  PubMed  CAS  Google Scholar 

  36. Lyon DJ, Chapman CS, Martin C, Brown KE, Clewley JP, Flower AJE, Mitchell VE (1989) Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate. Lancet i :1085

    Article  Google Scholar 

  37. Johnson B (1984) Parvovirus Proteins: In: Berns KJ (Hrsg.) The parvoviruses. New York London, Plenum Press, 1984, S. 259–295

    Google Scholar 

  38. Siegl G: Biology and pathogenicity of autonomous parvoviruses. In: Berns KJ (Hrsg.) The parvoviruses. New York, Plenum Press, 1984, S. 297–362

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. München, Germany

    T. F. Schwarz

Authors
  1. T. F. Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abt. Hämatologie und Onkologie, Universitäts-Kinderklinik, Martinistraße 52, D-2000, Hamburg 20, Deutschland

    G. Landbeck

  2. Osterwaldstr. 16, D-8000, München 40, Deutschland

    R. Marx

  3. Zentrum der Inneren Medizin, Abt. für Angiologie, Universitätsklinikum, Theodor-Stern-Kai 7, D-6000, Deutschland

    I. Scharrer

  4. Hämostaseologische Abt., Med. Klinik Innenstadt der Univ., Ziemssenstr. 1 a, D-8000, München 2, Deutschland

    W. Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schwarz, T.F. (1990). Parvovirus B19-Infektion. In: Landbeck, G., Marx, R., Scharrer, I., Schramm, W. (eds) 20. Hämophilie-Symposion Hamburg 1989. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75923-9_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-75923-9_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-52929-3

  • Online ISBN: 978-3-642-75923-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation